2024 annual financial data
Kazia Therapeutics 2024 Operating margin
Direct answer
Operating margin was -1,233.19%.
Operating income was -28,462,000 AUD and net income was -26,778,000 AUD.
Operating cash flow was -9,581,000 AUD.
Get free Kazia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,308,000 AUD
- Operating income
- -28,462,000 AUD
- Net income
- -26,778,000 AUD
- Operating cash flow
- -9,581,000 AUD